Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00102193 · ClinicalTrials.gov registry record · Phase 3
Study for the Treatment of Ulcerative Colitis With Adacolumn
A Phase 3 study, sponsored by Otsuka America Pharmaceutical.
- Completed
- Registry status
- Phase 3
- Development phase
- 168
- Enrollment target
NCT00102193 is a Phase 3 study that has completed, run by Otsuka America Pharmaceutical. The registered enrollment target is 168 participants.
The verdict
NCT00102193, a Phase 3 study, has completed, sponsored by Otsuka America Pharmaceutical.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 168 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate the safety and effectiveness of the Adacolumn Apheresis System to treat the signs and symptoms of ulcerative colitis.
Interventions
- DEVICE Adacolumn Apheresis System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2004-07 |
| Est. Completion | 2006-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00102193
The ClinicalTrials.gov registry entry for NCT00102193 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Otsuka America Pharmaceutical, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Adacolumn Apheresis System is the first listed.
NCT00102193 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00102193 about?
NCT00102193 is a clinical study titled "Study for the Treatment of Ulcerative Colitis With Adacolumn". The purpose of this study is to demonstrate the safety and effectiveness of the Adacolumn Apheresis System to treat the signs and symptoms of ulcerative colitis.
What is the current status of trial NCT00102193?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 168 participants. The study started on 2004-07. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00102193?
The interventions under investigation include: Adacolumn Apheresis System (DEVICE).
Who is sponsoring clinical trial NCT00102193?
This trial is sponsored by Otsuka America Pharmaceutical, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.